References
Squatrito D, Colagrande S, Emmi L (2010) Devic’s syndrome and primary APS: a new immunological overlap. Lupus 19(11):1337–1339
Terrell DR, Williams LA, Vesely SK et al (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 3:1432
Sarode R, Bandarenko N, Brecher ME et al (2014) Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher 29(3):148–167
Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P (2015) Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathol Biol (Paris) 63(3):136–143
Janius S, Jacobi C, de Seze J et al (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17(9):1067–1073
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest in this study.
Ethical approval
The ethics committee of the Tehran University of Medical Sciences approved the study on the basis of Helsinki declaration.
Informed consent
Written informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Okhovat, A.A., Ansari, B., Rezaali, S. et al. Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report. Acta Neurol Belg 117, 757–759 (2017). https://doi.org/10.1007/s13760-016-0710-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-016-0710-6